Christopher Halliday

With over 25 years of experience at the intersection of innovation and law, patent attorney Chris Halliday is a recognized leader in patent prosecution, transactions, and corporate diligence within the life sciences sector.

Chris leverages his extensive background to deliver strategic intellectual property counsel to companies ranging from emerging life science biotech and medtech firms to global pharmaceutical giants. His practice is rooted in guiding clients through the complexities of patent prosecution, particularly in biologics, pharmaceuticals, and medical devices. His deep understanding of the life sciences ecosystem enables him to anticipate challenges and craft comprehensive IP strategies that align with business objectives, protect innovation, and maximize market exclusivity.

He also regularly advises on IP-driven transactions, including mergers, acquisitions, and licensing agreements, ensuring that his clients’ intellectual assets are safeguarded and optimized for commercial success. Chris also plays a pivotal role in corporate due diligence, helping investors and companies navigate the risks and opportunities associated with high-value acquisitions and investments. His ability to distill complex scientific concepts into actionable legal strategies has earned him the trust of both R&D-driven enterprises and major venture capital firms. Chris' collaborative approach extends across Offit Kurman's network, allowing him to provide seamless support for multinational clients facing cross-border IP challenges. His commitment to staying at the forefront of technological advancements, coupled with his strategic insight, positions him as a go-to advisor for life sciences innovators looking to protect and capitalize on their intellectual property.

He is a sought-after speaker on patent law trends in life sciences and regularly contributes to leading legal and industry publications.